News Results for Astrazeneca (AZN)

Positive factory data from China and the UK put the FTSE 100 in a happy place on 1 December, approaching midday the index was up more than 2% to close on the 6,400 mark. Sterling remained volatile...

UK stocks opened more than 1% higher on Tuesday, paring Monday's losses, as positive Chinese factory data fueled global recovery hopes already supported by upbeat Covid-19 vaccine developments. At...

Pharmaceutical giant AstraZeneca agreed to sell the rights to Crestor and associated medicines in over 30 countries in Europe, except the UK and Spain, to Grunenthal for up to $350 million. The...

Having started the day in the black the FTSE 100 closed down more than 1% and falling below the 6,300 mark. In doing so it took its cue from the US where the S&P 500 was down 0.9% to 3,604.30...

The FTSE 100 surrendered earlier gains to trade flat at midday at 6,365.18. Contributing to the intra-day decline in the fortunes of the index were raised hopes of a Brexit deal. These helped push...

UK stocks made modest gains on Monday morning as investors weighed optimism about a potential Covid-19 vaccine against fears of a more severe economic fallout from the pandemic as cases continue to...

Pharmaceutical giant AstraZeneca said its diabetes drug Forxiga had been approved in Japan to treat patients with chronic heart failure. The approval was based on positive results from the DAPA-HF...

The UK's leading shares continued to drift lower at lunchtime on Friday as investors mull new sweeping stiff restrictions that will see limited opportunities for thousands of businesses across...

London's FTSE 100 struggled to make headway on Monday, creeping into the red by the close on news the coronavirus vaccine developed by Oxford University, and to be manufactured by pharmaceutical...

UK stocks began the week strongly on news the coronavirus vaccine developed by Oxford University, and to be manufactured by pharmaceutical giant AstraZeneca, has been shown to be 70% effective in...

UK stocks opened higher on Monday after pharmaceutical company AstraZeneca released positive trial results for a Covid-19 vaccine, adding to recent encouraging results from rivals Pfizer and...

Pharmaceutical company AstraZeneca said clinical trials in the UK and Brazil showed its Covid-19 vaccine, being developed with Oxford University, had an average efficacy of 70% in protecting...

Amid several competing catalysts around Brexit, Covid and vaccines the FTSE 100 closed out the week up 0.3% at 6,351.45. In the US the S&P 500 retreated 0.16% to 3,575,98 by 4.30pm UK time....

Sterling nudged slightly ahead amid briefings suggesting a Brexit deal is gradually moving closer. By midday the FTSE 100 was up 0.5% to 6,366.15, with US futures markets suggesting a mixed open on...

The FTSE 100 index was broadly flat in early trading this morning as more positive news emerged about potential Covid-19 vaccines. Shares in software company Sage Group dropped 10.9% to 606p after...

Pharmaceutical giant AstraZeneca said its antibody imfinzi had been approved in the US for an additional dosing option to treat non-small cell lung cancer after chemoradiation therapy and...

News that a member of the EU's Brexit negotiating team is isolating after testing positive for coronavirus, with talks put on on hold, as well as continuing fears over the economic impact of the...

Tightened restrictions in the US amid a worsening Covid situation helped push the FTSE 100 lower, by midday the index was down 0.8% to 6,334.75 with US futures pointing to future weakness on Wall...

UK stocks turned negative after opening higher Thursday as fears about a longer lockdown overshadowed positive vaccine news amid worries that Covid-19 restrictions will slow the economic recovery....

The FTSE 100 closed 1.79% higher to 6,296.85 on Tuesday as the positive sentiment imbued by encouraging news on a Covid-19 vaccine continues to hold. Stocks beaten down in the wake of the pandemic...

The FTSE 100 was up 0.9% to 6,241.95 in early trading building on the substantial gains chalked up yesterday thanks to positive news on a Covid-19 vaccine being developed by Pfizer. Real estate...

AstraZeneca and Amgen announced positive results from the NAVIGATOR Phase III trial for the potential new medicine tezepelumab in patients with severe, uncontrolled asthma. NAVIGATOR met the...

The FTSE 100 exploded into life just before lunch on Monday on news that a vaccine being developed by Pfizer is 90% effective against Covid. The FTSE 100 was up 3.4% to 6,112.64 on hopes that the...

The FTSE 100 rose after markets opened this morning as enthusiasm stayed strong in the aftermath of Joe Biden's US election victory. British house builder Taylor Wimpey has said it expects to end...

AstraZeneca's said its drug Calquence had received European Union approval for the treatment of adult patients with chronic lymphocytic leukaemia (CCL) adding to approvals already received in the...

With Biden leading in the key swing state of Philadelphia and a better-than-expected US jobs report out the muted reaction in the markets suggested the likely outcome of the election had already...

FTSE dips back below 5,900 with US election and jobs report in focus The FTSE 100 lost some ground by midday, down 0.1% to 5,897.03, after a strong run this week around the US election. Incumbent...

Drugmaker AstraZeneca said its Brilinta drug was approved in the US to reduce the risk of stroke or death in patients with acute ischemic stroke or high-risk transient ischaemic attack. The...

The FTSE 100 closed above 5,900 for the first time since mid-October as investors continued to await the result of a tight and contentious presidential election which appears to be heading the way...

By midday the FTSE 100 was solidly higher, up 0.4% at 5,906.14, after the Bank of England a new £150 billion stimulus package and most observers (and the bookmakers) pointed to Joe Biden as the...

The FTSE 100 index rose in the early hours of trading this morning despite Brexit jitters as Joe Biden’s election victory came into view, while the Bank of England boosted its quantitative easing...

Pharma giant AstraZeneca maintained its guidance after reporting a jump in third-quarter profit as revenue was boosted by strength in its portfolio of cancer drugs. For the three months ended...

UK equities ended Wednesday's session in positive territory despite the result of the US election hanging in the balance, with postal ballots still being counted. A change at the White House is...

With the result of the US election still in doubt as postal ballots continue to be counted the FTSE 100 shrugged off the uncertainty. It joined other European markets in moving higher amid signs...

Incumbent Donald Trump's decision to claim victory and call for the counting of votes to be stopped in a very tight presidential election led to nervousness in the markets on Wednesday morning....

Pharma giant AstraZeneca said it had agreed to sell the rights to Atacand and Atacand Plus, both used to treat heart failure and hypertension, in around 70 countries to Cheplapharm for $400...

Pharma giant AstraZeneca said Chinese health authorities had updated the label for Forxiga to include data from a clinical trial showing the drug 'significantly' reduced heart failure or death in...

The FTSE 100 closed 0.26% higher at 5,900.07, taking its cue from a strong start to trading on Wall Street amid continuing hopes that a stimulus package can be agreed between Democrats and...

Weakness in the pound amid warnings on the health of the UK economy from the Bank of England and concerns over a no deal Brexit helped erase the FTSE 100's losses by lunchtime on Tuesday. A fall...

Pharmaceutical giant AstraZeneca said its non-small-cell lung cancer drug candidate had been been given a regulatory nod for priority review in the US. Tragrisso had received acceptance for a...

The FTSE 100 closed firmly lower, down 0.6% at 5,884.65, not helped by strength in sterling amid signs negotiations between the EU and UK are set to intensify despite tough rhetoric on both sides....

The FTSE 100 lost ground by lunchtime to trade 0.2% lower at 5,910.59 as an initial kicker from US stimulus hopes, vaccine developments and Chinese economic data waned. European markets also...

UK stocks opened higher on Monday amid hopes that US lawmakers can agree on a fresh round of stimulus, as the Covid-19 caseload continues to surge around the globe. At 0826, the benchmark FTSE 100...

Pharmaceutical giant AstraZeneca said its diabetes drug had been recommended for marketing authorisation in the European Union to treat chronic heart failure with reduced ejection fraction in...

UK stocks traded sideways at lunchtime on Monday as investors readied themselves for the introduction of new local Covid-19 measures to be outlined later in the day by prime minister Boris...

UK stocks opened lower on Monday as investors braced for the introduction of new local Covid-19 restrictions, expected to be outlined later in the day by Prime Minister Boris Johnson. At 0826, the...

Pharmaceutical company AstraZeneca said its coronavirus antibody treatment would advance to two separate phase-three clinical trials at sites in and outside the US that would begin in the coming...

UK stocks traded lower at midday on Friday following weaker European markets as risk aversion was the order of the day amid rising volatility after news that Donald Trump tested positive for...

UK stocks opened lower on Friday after Donald Trump tested positive for Covid-19, adding an extra element of political uncertainty in the US just a month before the presidential election. At 0828,...

Pharmaceutical company AstraZeneca said its diabetes drug had been granted breakthrough therapy designation in the US to treat patients with chronic kidney disease with and without type-2...

Pharmaceutical company AstraZeneca and Merck said their drug to treat prostate cancer had received marketing authorisation in the European Union. The approval was based on a subgroup analysis of...

UK stocks closed slightly lower on Monday, despite positive Covid-19 vaccine news over the weekend from AstraZeneca and Pfizer. At 16:30, the benchmark FTSE 100 index was down 0.1%, at 6,032....

UK stocks drifted lower during the morning session on Monday, despite positive Covid-19 vaccine news over the weekend from AstraZeneca and Pfizer. At 12:00, the benchmark FTSE 100 index was down...

Pharma giant AstraZeneca said it had resumed British clinical trials of its Covid-19 vaccine following a brief pause that was caused by a participant experiencing an adverse reaction. Clinical...

UK stocks opened higher on Monday, buoyed by positive Covid-19 vaccine news over the weekend from AstraZeneca and Pfizer. At 0830, the benchmark FTSE 100 index was up 34.72 points, or 0.6%, at...

The FTSE 100 recovered some of its losses in afternoon trading on Thursday to move back above the 6,000 mark, as a weaker pound helped the index. The currency fell significant against the euro and...

The FTSE 100 fell sharply by lunchtime trading on Thursday as it was revealed the Government's mass coronavirus testing plan will cost £100bn, according to a leaked memo seen by the British Medical...

The UK's flagship index is off to a shaky start as it was revealed that Prime Minister Boris Johnson's plans to implement mass COVID-19 testing, which would see millions of people tested daily and...

Pharma giant AstraZeneca said the phase 3 trial for its drug to treat patients with chronic rhinosinusitis with nasal polyps had met its primary objectives. Results from study showed...

AstraZeneca and Oxford University reportedly paused their Covid-19 vaccine study after a UK participant in the trial suffered a suspected serious adverse reaction, according to Stat News....

UK stocks finished in negative territory on Tuesday, despite an advance for stocks on Wall Street, as a stronger pound weighed on exporters, offsetting some encouraging Chinese and UK manufacturing...

UK stocks edged lower on Tuesday after a stronger pound weighed on exporters, offsetting some positive manufacturing data from China. Financial stocks also weighed on the FTSE 100 with investors...

UK stocks edged lower in early trade on Tuesday after a stronger pound weighed on exporters, offsetting some positive manufacturing data from China. At 0827, the benchmark FTSE 100 index was down...

Pharmaceutical company AstraZeneca reported positive clinical results for its drug to treat patients with chronic kidney disease with and without type-2 diabetes. Results from the phase III...

Gene and cell therapy group Oxford Biomedica said it had signed an 18-month supply agreement with AstraZeneca for commercial manufacture of a Covid-19 vaccine candidate. The deal was part of a...

After rallying over 1% this morning, the FTSE 100 swung the other way on Tuesday afternoon to close deeply in the red, as a surging pound and plummeting US consumer confidence dragged the index...

UK stocks opened 1% higher on Tuesday after the US and China said they'd made progress in trade talks and software group Aveva announced a bumper $5bn (£3.8bn) takeover deal. At 0819, the...

Pharma giant AstraZeneca said the first participants had been dosed in a phase I trial of its potential Covid-19 treatment. The trial, called NCT04507256, would evaluate the safety,...

UK markets closed on Monday firmly in positive territory buoyed by new hopes that a leading Covid-19 vaccine contender could be approved for use in the next couple of months, while takeover...

UK markets rallied strongly through the morning session on Monday, buoyed by new hopes that a leading Covid-19 vaccine contender could be approved for use in the next couple of months, and takeover...

AstraZeneca rose on Monday after the Financial Times reported that the Trump administration was considering fast-tracking approval of its Covid-19 vaccine ahead of the US presidential election in...

UK stocks opened substantially higher on Monday amid hopes that a leading Covid-19 vaccine contender could be approved for use in the next couple of months. At 0824, the benchmark FTSE 100 index...

London's FTSE 100 ended Friday's session in the red as a resurgence of Covid-19 cases in Europe, a growing number of outbreaks in the UK and a warning from Michel Barnier that a UK-EU Brexit trade...

Britain's main stock index edged higher on Friday, despite skittishness caused by a resurgence of Covid-19 cases in Europe. At 11.36, the benchmark FTSE 100 index was marginally higher, up 0.02%...

Kidney disease diagnostics group Renalytix AI said it would collaborate with AstraZeneca to develop medicine strategies for cardiovascular, renal and metabolic diseases. The first stage in the...

Britain's main stock index fell below the 6,000-point mark in early trading on Friday, despite the release of positive retail sales figures, as investors remained wary of a resurgence of Covid-19...

Pharmaceutical giant AstraZeneca said its drug to treat patients with extensive-stage small cell lung cancer had been approved in Japan. Imfinzi (durvalumab) had been approved in combination with...

Pharmaceutical company AstraZeneca's Imfinzi has received acceptance for its Biologics License Application and been granted Food and Drug Administration (FDA) priority review in the US for a new...

Drug developer Redx Pharma said it had signed a significant out-licensing agreement for its fibrotic diseases treatment with AstraZeneca. AstraZeneca would take Redx Pharma's porcupine inhibitor,...

Pharmaceutical company AstraZeneca said it had priced a $3bn bond offering to fund general corporate purposes. The three-tranched offering, expected to close on 6 August, included $1.2bn of...

Credit Suisse today reaffirms its outperform investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9500p (from 9000p). Story provided by StockMarketWire.com Broker...

DZ Bank today reaffirms its sell investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 7500p (from 7300p). Story provided by StockMarketWire.com Broker Forecasts data...

Barclays Capital today reaffirms its overweight investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9300p (from 9200p). Story provided by StockMarketWire.com Broker...

Pharmaceutical company AstraZeneca said it had appointed Michel Demare as a member and chairman of the remuneration committee, with effect from 1 August 2020. Current remuneration committee...

Pharmaceutical company AstraZeneca said its chronic leukaemia and lung cancer treatments had been recommended for marketing authorisation in the European Union. The positive recommendation for...

Biopharmaceutical company AstraZeneca said its drug to treat patients with chronic kidney disease had met its primary and secondary goals. Results from AstraZeneca's Farxiga (dapagliflozin) phase...

Pharmaceutical company AstraZeneca said its drug to treat chronic obstructive pulmonary disease had been approved in the US. The approval of BreztriAerosphere by the US Food and Drug...

UK stocks ended Monday's trading session modestly lower as worries over the size of future financial packages in Europe and the US overshadowed positive Covid-19 vaccine and treatment data and oil...

Pharmaceutical company AstraZeneca said a potential Covid-19 vaccine generated a 'robust' immune response against the SARS-CoV-2 virus in all participants, in a trial being led by Oxford...

The UK's flagship index ended in negative territory on Thursday as the global number of coronavirus cases topped 12 million and US markets followed Europe lower, despite gradual improvements to US...

The UK's flagship index traded lower on Thursday as the global number of coronavirus cases topped 12 million and UK Chancellor Rishi Sunak warned of 'difficult times ahead' in a TV interview this...

The UK's flagship index has headed lower on opening as the global number of coronavirus cases topped 12 million and UK Chancellor Rishi Sunak warned of 'difficult times ahead' in a TV interview...

Pharma giant AstraZeneca said the US Food and Drug Administration had accepted supplemental new drug application and granted priority review for a drug used to reduce subsequent stroke in patients...

Pharma giant AstraZeneca said a pancreatic cancer treatment, jointly developed with Merck, had been approved in the European Union. The approval by the European Commission was based on results...

Pharma giant AstraZeneca said its drug to treat neurofibromatosis type 1, a rare and debilitating genetic disease, had been granted orphan drug designation in Japan. Selumetinib, neurofibromatosis...

Oddo today downgrades its investment rating on AstraZeneca PLC (LON:AZN) to reduce (from buy) and cut its price target to 7600p (from 8100p). Story provided by StockMarketWire.com Broker...

The FTSE 100 recovered some ground by lunchtime on Monday to trade back above the 6,000 mark, though there is still plenty of nervousness around about a second wave in the coronavirus pandemic...

Drugmaker AstraZeneca said it had reached an agreement with Europe's Inclusive Vaccines Alliance to supply up to 400m doses of the University of Oxford's COVID-19 vaccine. Deliveries of the...

The FTSE 100 ended Monday in the red after a mixed day for the index saw optimism over an economic recovery offset by investors' profit taking and pharmaceutical giant AstraZeneca falling on merger...